Information for the public
Benefits and risks
Benefits and risks
When NICE looked at the evidence, it decided that it showed normothermic extracorporeal preservation of hearts for transplantation following donation after brainstem death to be safe enough and work well enough for people with chronic heart failure needing a heart transplant. The 4 studies that NICE looked at involved a total of 337 patients. If you want to know more about the studies, see the guidance. Ask your health professional to explain anything you don't understand.